Sign in
Neurocognitive function of children treated for high-risk B-acute lymphoblastic leukemia (HR-ALL) randomized to Capizzi (CMTX) versus high-dose methotrexate (HDMTX): A report from the Children’s Oncology Group (COG)
Journal article   Peer reviewed

Neurocognitive function of children treated for high-risk B-acute lymphoblastic leukemia (HR-ALL) randomized to Capizzi (CMTX) versus high-dose methotrexate (HDMTX): A report from the Children’s Oncology Group (COG)

Naomi J. Winick, Leanne M Embry, Kristina K. Hardy, John A Kairalla, Meenakshi Devidas, Daniel Armstrong, Stephen Hunger, William L. Carroll, Eric Larsen, Elizabeth A. Raetz, …
Journal of clinical oncology, Vol.33(15_suppl), pp.10002-10002
2015-05-20

Metrics

5 Record Views

Details